Would you offer a bone marrow biopsy to the patient with normal CBC and low MDS-associated mutation burden found on NGS?   

E.g. TET2 mutation at < 10% allele frequency

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at The Center for Hematology and Oncology at Holy Cross Hospital
Agree. Would not do it, marrow biopsy.
Sign in or Register to read more